Active Detection of the Extension of Atherothrombosis in High Risk Coronary Patients

NCT00445835 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 526

Last updated 2020-01-22

No results posted yet for this study

Summary

Coronary artery disease is the first cause of death related to atherothrombosis.

Conditions

Interventions

OTHER

Arterial doppler for screening asymptomatic and significant extracoronary arterial stenoses in all arterial beds

A strategy of systematic screening of these extra-coronary asymptomatic lesions combined with a specific treatment if needed and an aggressive secondary prevention pharmacological treatment of atherothrombosis

OTHER

Conservative arm

Conservative medical approach

Sponsors & Collaborators

  • Institut de l'Atherothrombose

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Jean-Philippe COLLET, MD PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00445835 on ClinicalTrials.gov